Results of the 2020 Annual General Meeting of Biofrontera AG
Retrieved on:
Thursday, May 28, 2020
Leverkusen, Germany, May 28, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, an international biopharmaceutical company, announces the results of the Annual General Meeting (AGM) held today on May 28, 2020.
Key Points:
- Leverkusen, Germany, May 28, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, an international biopharmaceutical company, announces the results of the Annual General Meeting (AGM) held today on May 28, 2020.
- The shareholders approved the resolutions 2 to 6 proposed by the Management Board and Supervisory Board, published in the Federal Gazette on April 21, 2020.
- Resolution 7 as well as all supplementary motions submitted by the Deutsche Balaton Group did not obtain the required majorities and were rejected by the Annual General Meeting.
- Further information on the Annual General Meeting including the detailed voting results and the Management Board presentation can be found at: https://www.biofrontera.com/en/investors/annual-general-meeting